Evidence map›Paper›PMID 10051654›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Continuous axenic cultivation of Pneumocystis carinii.

S Merali, U Frevert, J H Williams, K Chin, R Bryan, A B Clarkson

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Axenic Long-Term Cultivation ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Pneumocystis.Cold Spring Harbor perspectives in medicine · 2014
    Review
  11. Update on the diagnosis and treatment of Pneumocystis pneumonia.Therapeutic advances in respiratory disease · 2011
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S MeraliDepartment of Medical and Molecular Parasitology, New York University School of Medicine, 341 East 25th Street, New York, New York, 10010, USA.
U Frevert
J H Williams
K Chin
R Bryan
A B Clarkson

Funding

PNEUMOCYSTIS CARINII THERAPY BY IRON CHELATIONR01AI038825 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CLARKSON JR, ALLEN B · 1996 to 1998
–
NIAID NIH HHS R01 AI38825
6 · The paper itself

Abstract

Continuous axenic culture of Pneumocystis carinii has been achieved. A culture vessel is used that allows for frequent medium exchange without disturbance of organisms that grow attached to a collagen-coated porous membrane. The growth medium is based on Minimal Essential Medium with Earle's salt supplemented with S-adenosyl-L-methionine, putrescine, ferric pyrophosphate, N-acetyl glucosamine, putrescine, p-aminobenzoic acid, L-cysteine and L-glutamine, and horse serum. Incubation is in room air at 31 degrees C. The pH of the medium begins at 8.8 and rises to approximately 9 as the cells grow. Doubling times calculated from growth curves obtained from cultures inoculated at moderate densities ranged from 35 to 65 hours. With a low-density inoculum, the doubling time is reduced to 19 hours. The morphology of cultured organisms in stained smears and in transmission electron micrographs is that of P. carinii, and P. carinii-specific mAbs label the cultured material. Cultured organisms are infective for immunosuppressed rats and can be stored frozen and used to reinitiate culture.

Indexed as

Adenosine TriphosphateAnimalsAntibodies, MonoclonalBloodCell DivisionCulture MediaHorsesHydrogen-Ion ConcentrationImmunosuppression TherapyKineticsLungMycologyPneumocystisPneumonia, PneumocystisRatsTime FactorsAdenosine TriphosphateAntibodies, MonoclonalCulture Media

Identifiers

PMID10051654
PMCPMC26796

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.